Product Information
YKL-06-062 is a drug that can be used to treat skin cancer. It is a small molecule that works by regulating the activity of two enzymes, dephosphorylation and protein kinase C. YKL-06-062 inhibits the production of eumelanin by targeting cyclic AMP activated protein kinase (AMPK), which regulates the synthesis of melanin. By inhibiting this enzyme, YKL-06-062 prevents cells from producing melanin, thereby decreasing the risk for skin cancer. YKL-06-062 also has an impact on immunity, as it stimulates T cells to produce more cytokines, which are proteins that regulate immune responses.
Chemical properties
Technical inquiry about: 3D-XLD61716 YKL-06-062
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
